14 results
20-F
2020 FY
PRFX
PainReform Ltd
18 Mar 21
Annual report (foreign)
9:03am
; and
not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation … , including:
the potential disruption of our ongoing business;
the distraction of management away from the ongoing oversight of our existing business
6-K
EX-99.1
PRFX
PainReform Ltd
9 Nov 20
PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors
10:30am
oversight of finance, business development, and manufacturing functions. He has been involved in numerous mergers and acquisitions, including the billion
424B4
PRFX
PainReform Ltd
2 Sep 20
Prospectus supplement with pricing info
4:09pm
to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation … of risks, including:
the potential disruption of our ongoing business;
the distraction of management away from the ongoing oversight of our existing
F-1/A
t009eunpdpcnj4 isfyl
31 Aug 20
Registration statement (foreign) (amended)
6:06am
F-1/A
yddp q2a5a0sdf6cqi6c
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
2krytdktd4id4k08
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
F-1/A
yctongqn
5 Aug 20
Registration statement (foreign) (amended)
1:26pm
F-1
EX-3.1
lvb5dy34ul
30 Jun 20
Registration statement (foreign)
5:16pm
F-1
687lzcyc 0e2
30 Jun 20
Registration statement (foreign)
5:16pm
DRS/A
l3ifkp dad
2 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
byk1hjm6mp5p
12 May 20
Draft registration statement (amended)
12:00am
DRS
j8kakjr4yxwuq
3 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next